ProCE Banner Series

Therapeutic Strategies for Patients With Hormone-Sensitive Prostate Cancer Across the Disease Continuum

Register today for this live, 1-hour, CME/CE-CPE-certified workshop series on optimal community care of patients with hormone-sensitive prostate cancer! After the webinar, download the associated slideset on management of HSPC.

To Register: Please click the green “Learn More” button below. On the next page, select Register for Virtual Event. Once registered, you will receive a confirmation email. Follow-up emails with event details will be sent as the event nears.

  ACPE
  | AMA
  | ANCC
Who Should Attend

The intended audience for this educational initiative is community oncologists, nurse practitioners, nurses, pharmacists, and other healthcare professionals who care for patients with hormone-sensitive prostate cancer.

All Events

Past Events

November

27

2023

Therapeutic Strategies for Patients With Hormone-Sensitive Prostate Cancer Across the Disease Continuum

11:30 AM - 12:30 PM Central Time (CT)

Virtual

Private Event, Mobile, Alabama

December

15

2023

Therapeutic Strategies for Patients With Hormone-Sensitive Prostate Cancer Across the Disease Continuum

8:30 AM - 9:30 AM Eastern Time (ET)

Virtual

Virtual Event | Host Group in VT, Bennington, Vermont

December

19

2023

Therapeutic Strategies for Patients With Hormone-Sensitive Prostate Cancer Across the Disease Continuum [Open Registration]

11:30 AM - 12:30 PM Central Time (CT)

Virtual

CCO Simulcast, Norman, Oklahoma

Topics

  • Welcome and Introduction
  • Background
  • Case Discussions on Treating HSPC
    • Metastatic HSPC
      • Risk assessment
      • Genetic testing
      • Current guidelines
      • Doublet and triplet therapies
      • Safety considerations
      • Future directions and ongoing trials
      • Shared decision-making
    • High-risk nonmetastatic HSPC
      • Risk stratification
      • Current guidelines
      • Future directions and ongoing trials
  • Audience Question and Answer Session

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act 
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact customer support prior to the live event.

CME/CE Info

Goal Statement
The goal of this activity is to improve learners’ knowledge, competence, and performance in applying practice-changing clinical data and expert recommendations to integrate the use of currently available therapies for their patients with hormone-sensitive prostate cancer. 

Target Audience
The intended audience for this educational initiative is community oncologists, nurse practitioners, nurses, pharmacists, and other healthcare professionals who care for patients with hormone-sensitive prostate cancer.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Incorporate risk stratification approaches to treat patients with early-stage prostate cancer that have demonstrated biochemical recurrence
  • Plan personalized therapeutic strategies for patients with mHSPC, considering all available agents, optimal agent sequence, available clinical data, expert recommendations, and patient goals and preferences
  • Counsel patients and their caregivers on the rationale and available options for hormone-sensitive prostate cancer, considering differences in administration, safety profiles, efficacy, and individual patient comorbidities and goals
  • Evaluate strategies to promote health equity in the care of patients with prostate cancer, including access to care, treatment, and clinical outcomes

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.1 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: JA4008176-0000-23-243-L01-P 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by Clinical Care Options, LLC.

Supported by an educational grant from Bayer HealthCare Pharmaceuticals Inc.

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191